Evidence map›Paper›PMID 33556408›Full record

ArticleJournal of molecular biology2021

The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins.

Kristina V Tugaeva, Dorothy E D P Hawkins, Jake L R Smith, Oliver W Bayfield, De-Sheng Ker, Andrey A Sysoev, Oleg I Klychnikov, Alfred A Antson, Nikolai N Sluchanko

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Mapping SARS-CoV-2 Nucleocapsid Function with Nanobodies.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. SARS-CoV-2 nucleocapsid protein directly prevents cGAS-DNA recognition through competitive binding.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Kristina V TugaevaA.N. Bach Institute of Biochemistry, Federal Research Center of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.
Dorothy E D P HawkinsYork Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, United Kingdom.
Jake L R SmithYork Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, United Kingdom.
Oliver W BayfieldYork Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, United Kingdom.
De-Sheng KerYork Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, United Kingdom.
Andrey A SysoevA.N. Bach Institute of Biochemistry, Federal Research Center of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.
Oleg I KlychnikovDepartment of Biochemistry, School of Biology, M.V. Lomonosov Moscow State University, 119991 Moscow, Russia.
Alfred A AntsonYork Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, United Kingdom. Electronic address: fred.antson@york.ac.uk.
Nikolai N SluchankoA.N. Bach Institute of Biochemistry, Federal Research Center of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia. Electronic address: nikolai.sluchanko@mail.ru.
University of York · GBA N Bach Institute of Biochemistry · RULomonosov Moscow State University · RU

Funding

Wellcome Trust 206377/Z/17/Z
6 · The paper itself

Abstract

The coronavirus nucleocapsid protein (N) controls viral genome packaging and contains numerous phosphorylation sites located within unstructured regions. Binding of phosphorylated SARS-CoV N to the host 14-3-3 protein in the cytoplasm was reported to regulate nucleocytoplasmic N shuttling. All seven isoforms of the human 14-3-3 are abundantly present in tissues vulnerable to SARS-CoV-2, where N can constitute up to ~1% of expressed proteins during infection. Although the association between 14-3-3 and SARS-CoV-2 N proteins can represent one of the key host-pathogen interactions, its molecular mechanism and the specific critical phosphosites are unknown. Here, we show that phosphorylated SARS-CoV-2 N protein (pN) dimers, reconstituted via bacterial co-expression with protein kinase A, directly associate, in a phosphorylation-dependent manner, with the dimeric 14-3-3 protein, but not with its monomeric mutant. We demonstrate that pN is recognized by all seven human 14-3-3 isoforms with various efficiencies and deduce the apparent K

Indexed as

14-3-3 ProteinsAmino Acid SequenceBinding SitesCoronavirus Nucleocapsid ProteinsCyclic AMP-Dependent Protein KinasesEscherichia coliHumansMutationPhosphopeptidesPhosphoproteinsPhosphorylationPhosphoserineProtein BindingProtein IsoformsRNA, ViralSubstrate Specificity14-3-3 ProteinsCoronavirus Nucleocapsid ProteinsCyclic AMP-Dependent Protein Kinasesnucleocapsid phosphoprotein, SARS-CoV-2PhosphopeptidesPhosphoproteinsPhosphoserineProtein IsoformsRNA, Viralhost-pathogen interactionsnucleocytoplasmic shuttlingphosphorylationprotein–protein complexstoichiometry

Identifiers

PMID33556408
PMCPMC7863765
OpenAlexW3128571690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.